Detailed answers about ISO AND PHARMA CONSULTANCY SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was ISO AND PHARMA CONSULTANCY SERVICES LIMITED founded?
ISO AND PHARMA CONSULTANCY SERVICES LIMITED was officially incorporated on 1 April 2026 and is registered under company number 17131325. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ISO AND PHARMA CONSULTANCY SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ISO AND PHARMA CONSULTANCY SERVICES LIMITED?
ISO AND PHARMA CONSULTANCY SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ISO AND PHARMA CONSULTANCY SERVICES LIMITED do?
ISO AND PHARMA CONSULTANCY SERVICES LIMITED operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is ISO AND PHARMA CONSULTANCY SERVICES LIMITED's registered address?
The registered office address of ISO AND PHARMA CONSULTANCY SERVICES LIMITED is 233 Brecon Road, Ystradgynlais, Swansea, Wales, SA9 1QN. This is the official address filed with Companies House for legal and statutory correspondence.
Is ISO AND PHARMA CONSULTANCY SERVICES LIMITED financially stable?
Financial accounts for ISO AND PHARMA CONSULTANCY SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.